I think Gardasil does hold promise, but when they don't know whether it will last beyond five years and it hasn't been tested with other vaccines.... The most important word in drug safety is contraindication. If it hasn't been tested with these 16 other vaccines, say, that little girls might have had before, they could run into contraindications. I'm saying it's unproven. I'm saying there are too many unknowns about it to ask every little 9- or 10-year-old girl to take these three painful needles.
There's another one coming out, by the way, following Gardasil, which will apparently protect against the other 30% of cancer-causing HPV. Who knows how they will react?
There are always questions, and you want the questions answered. You want to monitor patients very closely. You don't want a million little girls taking something when it's brand new. It's better to start it slowly with patients who are more willing, in this case--I was going to say patients who have the condition, but there is no condition yet--and build it up slowly, so that if it has a deadly side effect you can catch it before a million patients are exposed to it.